BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30564869)

  • 1. Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.
    Arout CA; Waters AJ; MacLean RR; Compton P; Sofuoglu M
    Psychopharmacology (Berl); 2019 Oct; 236(10):2857-2866. PubMed ID: 30564869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
    Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
    Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.
    Tompkins DA; Smith MT; Bigelow GE; Moaddel R; Venkata SL; Strain EC
    Clin J Pain; 2014 Jan; 30(1):36-45. PubMed ID: 23446076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans.
    Babalonis S; Lofwall MR; Sloan PA; Nuzzo PA; Fanucchi LC; Walsh SL
    Psychopharmacology (Berl); 2019 Nov; 236(11):3341-3352. PubMed ID: 31201479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose.
    Athanasos P; Ling W; Bochner F; White JM; Somogyi AA
    Pain Med; 2019 Jan; 20(1):119-128. PubMed ID: 29514333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.
    Rowbotham MC; Wallace M
    J Pain; 2020; 21(9-10):1031-1046. PubMed ID: 32006699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.
    Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL
    Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment.
    Ellis JD; Han D; Mayo J; Hobelmann JG; Finan PH; Huhn AS
    Br J Clin Pharmacol; 2024 Jun; 90(6):1408-1417. PubMed ID: 38417973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
    Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA
    Eur J Anaesthesiol; 2015 Apr; 32(4):248-54. PubMed ID: 24849503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.
    Compton PA; Ling W; Torrington MA
    Addict Biol; 2008 Sep; 13(3-4):393-402. PubMed ID: 18507735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.
    Worley MJ; Heinzerling KG; Shoptaw S; Ling W
    Exp Clin Psychopharmacol; 2015 Dec; 23(6):428-35. PubMed ID: 26302337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
    Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
    Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.
    Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD
    Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
    Hay JL; White JM; Bochner F; Somogyi AA; Semple TJ; Rounsefell B
    J Pain; 2009 Mar; 10(3):316-22. PubMed ID: 19101210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.
    Wang X; Jiang H; Zhao M; Li J; Gray F; Sheng L; Li Y; Li X; Ling W; Li W; Hao W
    Asia Pac Psychiatry; 2019 Mar; 11(1):e12344. PubMed ID: 30460781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
    Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA
    Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline Prevents Muscular Pain Hypersensitivity and Cutaneous Allodynia Produced by Repeated Intramuscular Injections of Hypertonic Saline in Healthy Human Participants.
    Samour MS; Nagi SS; Shortland PJ; Mahns DA
    J Pain; 2017 Aug; 18(8):994-1005. PubMed ID: 28396046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.